They found that the expression of key ERS genes (APAF1, BAX, PPP1R3C, PTPN1, and STC2) was significantly elevated in COPD patients, accompanied by a significant decrease in lung function–related indices, verifying the reliability of the results (28). This evidence concerns the gene APAF1 and chronic obstructive pulmonary disease.